Technical analysis of Regeneron Pharmaceuticals, Inc. (REGN): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Regeneron Pharmaceuticals, Inc. is a global biopharmaceutical enterprise focused on discovering, inventing, developing, manufacturing, and bringing to market medical treatments for a wide array of illnesses.
Price Performance
| 1 month | -5.08% |
| 3 months | +28.65% |
| Year-to-date | +1.66% |
| 1 year | +32.55% |
| 3 years | -5.65% |
| 5 years | +22.44% |
52-Week Range
| 52-week High | $859.34 |
| 52-week Low | $541.00 |
| Avg Volume (90d) | 891K |
Technical Indicators
| SMA 50 | $763.57 |
| SMA 200 | $733.80 |
| Beta | 0.40 |
| 30-day Volatility (annualised) | 27.5% |
| Price vs SMA 50 | +2.8% |
| Price vs SMA 200 | +6.9% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $651.80 | |
| 2025-11 | $780.19 | +19.7% |
| 2025-12 | $771.87 | -1.1% |
| 2026-01 | $741.45 | -3.9% |
| 2026-02 | $781.67 | +5.4% |
| 2026-03 | $772.64 | -1.2% |
| 2026-04 | $707.06 | -8.5% |
| 2026-05 | $614.78 | -13.1% |
| 2026-06 | $623.54 | +1.4% |
| 2026-07 | $762.63 | +22.3% |
| 2026-08 | $799.08 | +4.8% |
| 2026-09 | $784.67 | -1.8% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-16 | | $47M |
| 2026-09-16 | $-0.03 | $1M |
| 2026-09-16 | | $5M |
| 2026-09-16 | | |
| 2026-09-16 | $0.11 | $531M |
| 2026-09-16 | $0.18 | $3.43B |
Price
| Price | $784.85 |
| Market Cap | $80.9B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 18.61 |
| Price / Book | 2.54 |
| EV / EBITDA | 13.82 |
| Dividend Yield | 0.47% |
Financial Health
| Debt / Equity | 0.06 |
| Current Ratio | 3.34 |
| Piotroski F-Score | 2 |
| Altman Z-Score | 6.85 |